H

Humedix Co Ltd
KOSDAQ:200670

Watchlist Manager
Humedix Co Ltd
KOSDAQ:200670
Watchlist
Price: 45 250 KRW 7.74% Market Closed
Market Cap: 466.5B KRW
Have any thoughts about
Humedix Co Ltd?
Write Note

Humedix Co Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Humedix Co Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
H
Humedix Co Ltd
KOSDAQ:200670
Other Liabilities
â‚©556.3m
CAGR 3-Years
-44%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Other Liabilities
â‚©53.5B
CAGR 3-Years
-12%
CAGR 5-Years
-4%
CAGR 10-Years
16%
SK Biopharmaceuticals Co Ltd
KRX:326030
Other Liabilities
â‚©37.7B
CAGR 3-Years
1%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Other Liabilities
â‚©4.7B
CAGR 3-Years
-61%
CAGR 5-Years
-45%
CAGR 10-Years
-17%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Other Liabilities
â‚©42.1B
CAGR 3-Years
54%
CAGR 5-Years
29%
CAGR 10-Years
24%
C
Celltrion Pharm Inc
KOSDAQ:068760
Other Liabilities
â‚©9.6B
CAGR 3-Years
18%
CAGR 5-Years
26%
CAGR 10-Years
28%
No Stocks Found

Humedix Co Ltd
Glance View

Market Cap
470.4B KRW
Industry
Pharmaceuticals

Humedix Co., Ltd. engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2014-12-26. The firm distributes its products within domestic market and to overseas markets

Intrinsic Value
63 395.66 KRW
Undervaluation 29%
Intrinsic Value
Price
H

See Also

What is Humedix Co Ltd's Other Liabilities?
Other Liabilities
556.3m KRW

Based on the financial report for Sep 30, 2024, Humedix Co Ltd's Other Liabilities amounts to 556.3m KRW.

What is Humedix Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
12%

Over the last year, the Other Liabilities growth was -70%. The average annual Other Liabilities growth rates for Humedix Co Ltd have been -44% over the past three years , 12% over the past five years .

Back to Top